SEI Investments’s abrdn Life Sciences Investors HQL Stock Holding History

SEI Investments’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-484	Closed	-$9K	–	2894
2018 Q2	$9K	Buy	484 +20	+4%	+$376	﹤0.01%	3028
2018 Q1	$9K	Buy	464 +43	+10%	+$861	﹤0.01%	2900
2017 Q4	$8K	Buy	421 +9	+2%	+$180	﹤0.01%	2847
2017 Q3	$9K	Buy	+412	New	+$8.75K	﹤0.01%	2714

Other funds holding HQL

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

SEI Investments's HQL Position: Q3 2018 in Review

SEI Investments sold out of abrdn Life Sciences Investors (HQL) in Q3 2018, closing a stake of 484 shares — an estimated $9K sold.

SEI Investments first reported a position in HQL in Q3 2017 and held it in 4 quarters. The position peaked at $9K in Q2 2018. 57 funds tracked by Wall St. Rank hold HQL as of Q3 2018.

SEI Investments reported no remaining abrdn Life Sciences Investors position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 484 abrdn Life Sciences Investors shares in Q3 2018, an estimated $9K.
SEI Investments first reported a position in abrdn Life Sciences Investors in Q3 2017 and held it in 4 quarters.
SEI Investments's abrdn Life Sciences Investors position peaked at $9K in Q2 2018.
57 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.